A Phase II, Multicentre, Randomised, Assessor-Blinded, Active-Comparator, Parallel-Group Dose Finding Trial to Evaluate AS900672-Enriched [recombinant follicle stimulating hormone] Versus Follitropin Alfa (GONAL-f) in Oligo-Anovulatory Infertile Women Undergoing Ovulation Induction (OI)
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2018
At a glance
- Drugs Recombinant follicle-stimulating hormone (Primary) ; Follitropin alfa
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 17 Dec 2009 Actual patient number (71) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 29 Aug 2009 Status changed from recruiting to active, no longer recruiting.